"These findings indicated that improvement of insulin sensitivity and hypoglycemic effects of ME may be attributed to the inhibition of PTP1B. Thereby we pioneered the inhibitory potential of ME targeted on PTP1B as anti-T2DM drug discovery."xsd:string